Shanghai Stock Connect added 21 stocks on the Science and Technology Innovation Board yesterday_ Oriental Fortune Net Post date May 6, 2022 — 10:20 Post Lock Read More Gloria Spectrum completes a new round of financing of hundreds of millions of yuan, accelerating to lead the financing of innovative clinical products from multiple omics sources – yqqlm Post date May 5, 2022 — 12:51 Post Lock Read More 31 Sci-tech Innovation Board stocks received northbound funds to increase their positions_Oriental Fortune Network Post date April 28, 2022 — 11:28 Post Lock Read More Borui Pharmaceutical (688166): Resolution of the 7th meeting of the 3rd Supervisory Committee- CFi.CN Zhongcai Network Post date April 27, 2022 — 19:28 Post Lock Read More CDB Securities maintains the recommendation rating of Borui Pharmaceutical: Rapid growth in annual performance awaits the release of production capacity Post date April 26, 2022 — 23:53 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 13:08 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 11:36 Post Lock Read More National Core Technology (688262): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 21, 2022 — 22:46 Post Lock Read More Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network Post date April 19, 2022 — 18:19 Post Lock Read More Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Gloria Spectrum completes a new round of financing of hundreds of millions of yuan, accelerating to lead the financing of innovative clinical products from multiple omics sources – yqqlm Post date May 5, 2022 — 12:51 Post Lock Read More 31 Sci-tech Innovation Board stocks received northbound funds to increase their positions_Oriental Fortune Network Post date April 28, 2022 — 11:28 Post Lock Read More Borui Pharmaceutical (688166): Resolution of the 7th meeting of the 3rd Supervisory Committee- CFi.CN Zhongcai Network Post date April 27, 2022 — 19:28 Post Lock Read More CDB Securities maintains the recommendation rating of Borui Pharmaceutical: Rapid growth in annual performance awaits the release of production capacity Post date April 26, 2022 — 23:53 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 13:08 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 11:36 Post Lock Read More National Core Technology (688262): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 21, 2022 — 22:46 Post Lock Read More Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network Post date April 19, 2022 — 18:19 Post Lock Read More Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
31 Sci-tech Innovation Board stocks received northbound funds to increase their positions_Oriental Fortune Network Post date April 28, 2022 — 11:28 Post Lock Read More Borui Pharmaceutical (688166): Resolution of the 7th meeting of the 3rd Supervisory Committee- CFi.CN Zhongcai Network Post date April 27, 2022 — 19:28 Post Lock Read More CDB Securities maintains the recommendation rating of Borui Pharmaceutical: Rapid growth in annual performance awaits the release of production capacity Post date April 26, 2022 — 23:53 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 13:08 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 11:36 Post Lock Read More National Core Technology (688262): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 21, 2022 — 22:46 Post Lock Read More Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network Post date April 19, 2022 — 18:19 Post Lock Read More Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Borui Pharmaceutical (688166): Resolution of the 7th meeting of the 3rd Supervisory Committee- CFi.CN Zhongcai Network Post date April 27, 2022 — 19:28 Post Lock Read More CDB Securities maintains the recommendation rating of Borui Pharmaceutical: Rapid growth in annual performance awaits the release of production capacity Post date April 26, 2022 — 23:53 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 13:08 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 11:36 Post Lock Read More National Core Technology (688262): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 21, 2022 — 22:46 Post Lock Read More Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network Post date April 19, 2022 — 18:19 Post Lock Read More Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
CDB Securities maintains the recommendation rating of Borui Pharmaceutical: Rapid growth in annual performance awaits the release of production capacity Post date April 26, 2022 — 23:53 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 13:08 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 11:36 Post Lock Read More National Core Technology (688262): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 21, 2022 — 22:46 Post Lock Read More Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network Post date April 19, 2022 — 18:19 Post Lock Read More Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 13:08 Post Lock Read More Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 11:36 Post Lock Read More National Core Technology (688262): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 21, 2022 — 22:46 Post Lock Read More Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network Post date April 19, 2022 — 18:19 Post Lock Read More Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Slack (300382): The company renews the appointment of the 2022 audit institution CFi.CN Zhongcai Network Post date April 25, 2022 — 11:36 Post Lock Read More National Core Technology (688262): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 21, 2022 — 22:46 Post Lock Read More Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network Post date April 19, 2022 — 18:19 Post Lock Read More Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
National Core Technology (688262): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 21, 2022 — 22:46 Post Lock Read More Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network Post date April 19, 2022 — 18:19 Post Lock Read More Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Borui Pharmaceutical (688166): Held the 2021 Annual Results Briefing-CFi.CN Zhongcai Network Post date April 19, 2022 — 18:19 Post Lock Read More Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Feiliks (300240): intends to re-appoint the accounting firm in 2022 CFi.CN Zhongcai Network Post date April 19, 2022 — 05:06 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: the scale effect improves the connection between new and old varieties_Oriental Fortune Network Post date April 18, 2022 — 13:40 Post Lock Read More Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Zheshang Securities maintains the overweight rating of Borui Pharmaceutical: scale effect improves the connection between new and old varieties Post date April 18, 2022 — 13:40 Post Lock Read More Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Southwest Securities: Overweight rating for Borui Pharmaceuticals Post date April 17, 2022 — 17:41 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations – yqqlm Post date April 17, 2022 — 17:34 Post Lock Read More Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Southwest Securities gives Borui Pharmaceutical a hold rating: rapid growth in performance, rapid progress in domestic and foreign declarations Post date April 17, 2022 — 17:32 Post Lock Read More Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Highlights of important announcements of listed companies on April 16: Wen's shares will lose 13.404 billion yuan in 2021 – yqqlm Post date April 16, 2022 — 01:49 Post Lock Read More Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Borui Pharmaceutical (688166.SH) released its 2021 results, with a net profit of 244 million yuan, a year-on-year increase of 43.60%, and a distribution of 1.20 yuan per 10 shares Post date April 15, 2022 — 21:37 Post Lock Read More Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Borui Pharmaceutical: Net profit in 2021 is about 244 million yuan, an increase of 43.6% year-on-year Post date April 15, 2022 — 21:31 Post Lock Read More Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Borui Medicine: Net profit in 2021 will increase by 43.6% year-on-year, and 10 distributions of 1.2 yuan are planned – yqqlm Post date April 15, 2022 — 21:30 Post Lock Read More
Caishen.CoCaishen.Co